Applied Clinical Trials-05-01-2002

Letters to the Editor
Applied Clinical Trials

May 01, 2002

Readers respond to articles and editorials.

View from Brussels
Applied Clinical Trials

May 01, 2002

A new guideline details basic requirements for submitting a successful application for a proposed orphan drug in the European Union.

View from Washington
Applied Clinical Trials

May 01, 2002

Federal prosecutors target sponsors and clinical investigators who misuse federal funds or violate research requirements while FDA proposes new policies and Congress eyes reforms.

Feature Article
Applied Clinical Trials

May 01, 2002

Improving adverse event reporting can lead to improved safety profiles and, consequently, fewer drugs pulled from the market.

Meet the EAB
Applied Clinical Trials

May 01, 2002

Family man, educator, mentor, athlete--and a man on a quest with Amgen Inc for new and better oncology treatments.

Feature Article
Applied Clinical Trials

May 01, 2002

A new method, based on hard-earned experience, can help you reduce the risk of protocol inconsistencies and ambiguities during the protocol development process.